European Society of Toxicology In Vitro > News > JRC project to assemble Adverse Outcome Pathways (AOP) describing the course of the Covid-19 disease
21 July 2020

JRC project to assemble Adverse Outcome Pathways (AOP) describing the course of the Covid-19 disease

The European Commission’s Joint Research Centre (JRC) has instigated a project to assemble Adverse Outcome Pathways (AOP) describing the course of the Covid-19 disease from the molecular initiating event (e.g. ACE receptor binding) via a series of key events across different levels of biological organisation towards adverse clinical outcomes (e.g. respiratory failure, organ damage).

The aim is to deliver an inter- and crossdisciplinary description of the disease process(es) in a domain that still seems riddled with overspecialisation and research discipline tunnel vision. We argue that Covid-19 AOPs can function as an overarching knowledge entry point to Covid-19 research separating signal from noise and giving scientists the possibility to quickly grasp dependencies between research fields not normally collaborating.

To learn more, sign up for one of two introductory webinars (28 July and 4 August): https://ec.europa.eu/eusurvey/runner/Covid-19_AOP_Webinar

Related content

ESTIV Congress 2022

  • 0

Due to the COVID-19 pandemic and after thoughtful deliberation we have decided to postpone the congress to 2022 instead of the previously indicated dates in 2021. We kindly ask everyone to please save the new dates: 21-25 November 2022 . In the upcoming months, we will work on updating the website and determine a new list of important dates and deadlines for the congress. We look forward to gathering again in 2022 and in the meantime we wish everyone a healthy summer break!

ESTIV Early Career Award granted to Dr. Timothy Allen

  • 0

The European Society of Toxicology In Vitro (ESTIV) will grant an early career award for the first time in 2020 and intends to do so every 2 years coinciding with its biennial conferences…

ESTIV/ASCCT Webinars in 2020

Human biology-based approaches for COVID 19 therapeutics – that is the theme of the July 8 webinars presented by Malcolm Wilkinson and Samuel Constant…

Corporate Members

mattek in Vitro Life Science Laboratories

Gold Sponsor

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding